Loading...
•
Dec 31, 2019
Zoetis Q4 2019 Earnings Report
Zoetis reported a revenue increase of 7% and net income of $384 million for Q4 2019
Key Takeaways
Zoetis reported a strong fourth quarter and full year in 2019, with revenue reaching $1.7 billion for the quarter, a 7% increase compared to the previous year. Net income for the quarter was $384 million, or $0.80 per diluted share. The company is launching Simparica® Trio in 2020 and is focused on innovation and growth areas.
Zoetis reported revenue of $1.7 billion for Q4 2019, a 7% increase year-over-year.
Net income for Q4 2019 was $384 million, or $0.80 per diluted share.
Adjusted net income for Q4 2019 was $440 million, or $0.92 per diluted share.
The company is launching Simparica® Trio in 2020 and focusing on innovation.
Zoetis
Zoetis
Zoetis Revenue by Segment
Zoetis Revenue by Geographic Location
Revenue by Segment
Companion Animal Revenue
CapyFin.comLivestock Revenue
CapyFin.comContract Mfg. & Human Health Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Zoetis is providing full year 2020 guidance, which includes Revenue between $6.650 billion to $6.800 billion, Reported diluted EPS between $3.53 to $3.65 and Adjusted diluted EPS between $3.90 to $4.00.
Positive Outlook
- Revenue between $6.650 billion to $6.800 billion
- Operational growth 7.0% to 9.5%
- Adjusted cost of sales as a percentage of revenue 30% to 31%
- Adjusted SG&A expenses $1,590 to $1,640
- Adjusted R&D expenses $455 to $475
Revenue & Expenses
Visualization of income flow from segment revenue to net income